The Biosample Repository Facility (BRF) coordinates the ethical collection, storage, annotation and distribution of human biospecimens and associated clinical data and interventions, patient and family cancer history data, and lifestyle factors under Institutional Review Board-approved protocols. It adheres to the International Society for Biological and Environmental Repositories and National Cancer Institute Best Practices for Biospecimen Resources and participate in the NCI Office of Biorepositories and Biospecimen Resources and Biospecimen Research Network. The BRF expediates bidirectional flow from lab bench to clinic, and facilitates translational research associated with clinical trials and basic research. It provides tissue-based research services—including tissue microarray construction and immunohistochemistry and automated tissue image analysis—to support translational and basic research.
This facility derives partial funding from the FCCC Cancer Center Support Grant (CCSG) from the National Cancer Institute.